Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-06-03T05:00:30.493Z Has data issue: false hasContentIssue false

Chapter 31 - Menopausal syndrome

from Section V - Reproductive endocrinology and infertility

Published online by Cambridge University Press:  05 May 2016

Martin Olsen
Affiliation:
East Tennessee State University
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Office Care of Women , pp. 341 - 348
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Harlow, SD, Gass, M, Hall, JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97:1159–68.CrossRefGoogle ScholarPubMed
Van Voorhis, BJ, Santoro, N, Harlow, S, et al. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol 2008; 112:101–8.CrossRefGoogle ScholarPubMed
Randolph, JF Jr, Sowers, M, Bondarenko, I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005; 90:6106–12.CrossRefGoogle ScholarPubMed
Broer, SL, Eijkemans, MJ, Scheffer, GJ, et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011; 96:2532–9.CrossRefGoogle ScholarPubMed
Broer, SL, Willem, B, Hendriks, D, et al. Then role of antimullerian hormone in prediction of outcome after IVF – comparison with the antral follicle count. Fert Steril 2009; 91:705–14.CrossRefGoogle ScholarPubMed
Burger, HG, Hale, GE, Dennerstein, L, Robertson, DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008; 15:603–12.Google ScholarPubMed
Hee, J, MacNaughton, J, Bangah, M, Burger, HG. Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone. Maturitas 1993; 18:920.CrossRefGoogle Scholar
Ahmed Ebbiary, NA, Lenton, EA, Cooke, ID. Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women. Clin Endocrin 1994; 41:199206.CrossRefGoogle ScholarPubMed
Santoro, N, Brockwell, S, Johnston, J, et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women’s Health across the Nation. Menopause 2007; 14:415424.CrossRefGoogle ScholarPubMed
Luborsky, JL, Meyer, P, Sowers, MF, et al. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod; 18:199206.CrossRefGoogle Scholar
Marret, H, Fauconnier, A, Chabbert-Buffet, N. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol 2010; 152:133–7.CrossRefGoogle ScholarPubMed
Stearns, V, Ulmer, L, Lopez, JF, et al. Hot flushes. Lancet 2002; 360:1851–61.CrossRefGoogle ScholarPubMed
Kravitz, HM, Ganz, PA, Bromberger, J, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003; 10:1928.Google ScholarPubMed
Nedrow, A, Miller, J, Walker, M, et al. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006; 166:1453–65.CrossRefGoogle ScholarPubMed
Newton, KM, Reed, SD, LaCroix, AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006; 145:869–79.CrossRefGoogle ScholarPubMed
Taylor, HS, Manson, JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab 2011; 96:255–64.CrossRefGoogle ScholarPubMed
Simon, J, Portman, DJ, Kaunitz, AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause 2013; 20:1027–35.Google ScholarPubMed
Reddy, SY, Warner, H, Guttuso, T, et al. Gabapentin, estrogen, and placebo for treating hot flushes: A randomized controlled trial. Obstet Gynecol 2006; 108:41–8.CrossRefGoogle ScholarPubMed
Nagamani, M, Kelver, ME, Smith, ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 1987; 156:561–5.CrossRefGoogle ScholarPubMed
Bertelli, G, Venturini, M, Del Mastro, L, et al. Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Ann Oncol 2002; 13:883–8.CrossRefGoogle ScholarPubMed
Loprinzi, CL, Michalak, JC, Quella, SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994; 331:347–52.CrossRefGoogle ScholarPubMed
Studee, DW, Panay, N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010; 13:509–22.Google Scholar
Suckling, J, Lethaby, A, Kennedy, R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003; 4:CD001500.Google Scholar
Weisberg, E, Ayton, R, Darling, G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005; 8:8393.CrossRefGoogle ScholarPubMed
Simon, J, Nachtigall, L, Ulrich, LG, et al. Endometrial safety of ultra-low-dose estradiol vaginal tablets. Obstet Gynecol 2010; 116:876–83.CrossRefGoogle ScholarPubMed
Barlow, DH, Cardozo, LD, Francis, RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997; 104:8791.CrossRefGoogle ScholarPubMed
Cayan, F, Dilek, U, Pata, O, Dilek, S. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med 2008; 5:132–8.CrossRefGoogle ScholarPubMed
Shifren, JL, Braunstein, GD, Simon, JA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343:682–6.CrossRefGoogle ScholarPubMed
Somboonporn, W, Bell, RJ, Davis, SR. Testosterone for peri and postmenopausal women. Cochrane Database Syst Rev 2005 Oct 19; 4:CD004509.Google Scholar
Sarwer, DB, Durlak, JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. J Sex Marital Ther 1997; 23:8797.CrossRefGoogle ScholarPubMed
Greendale, GA, Derby, CA, Maki, PM. Perimenopause and cognition. Obstet Gynecol Clin North Am 2011; 38:519–35.CrossRefGoogle ScholarPubMed
Shaywitz, SE, Shaywitz, BA, Pugh, KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999; 281:1197–202.CrossRefGoogle ScholarPubMed
Lethaby, A, Hogervorst, E, Richards, M, et al. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2008 Jan 23; 1:CD003122.Google Scholar
Rapp, SR, Espeland, MA, Shumaker, SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289:2663–72.CrossRefGoogle ScholarPubMed
Avis, NE, Brambilla, D, McKinlay, SM, Vass, K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Ann Epidemiol 1994; 4:214–20.CrossRefGoogle ScholarPubMed
Freeman, EW, Sammel, MD, Lin, H, Nelson, DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63:375–82.CrossRefGoogle ScholarPubMed
Recker, R, Lappe, J, Davies, K, Heaney, R. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2000; 15:1965–73.CrossRefGoogle ScholarPubMed
Panula, J, Pihlajamäki, H, Mattila, VM, et al. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord 2011; 12:105.CrossRefGoogle ScholarPubMed
Rossouw, JE, Prentice, RL, Manson, JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297:1465–77.CrossRefGoogle ScholarPubMed
Santen, RJ, Allred, DC, Ardoin, SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010; 95:s1–s66.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×